Form 4: ALIGN TECHNOLOGY Director Britt J. Vitalone Granted Restricted Stock Units

ALIGN TECHNOLOGY Inc. Director Britt J. Vitalone was granted 1,443 restricted stock units, aligning his interests with shareholders.

Summary

• Britt J. Vitalone, a Director of ALIGN TECHNOLOGY INC (ALGN), was granted 1,443 Restricted Stock Units (RSUs).
• The transaction date for the grant was July 2, 2025.
• The RSUs have a conversion or exercise price of $0.0001, representing the par value of ALGN common stock.
• 100% of these RSUs will vest on the date of the next annual meeting of stockholders.
• Shares will be delivered upon vesting, contingent on Mr. Vitalone's continued service.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally a positive sign of alignment between management and shareholders, though it's a routine compensation event rather than a significant operational or financial announcement.

Positives

• The grant of Restricted Stock Units to a Director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• Equity compensation is a common method to incentivize long-term commitment and performance from key personnel.

Negatives

• The RSUs are subject to a vesting period, meaning the shares are not immediately owned and can be forfeited if service is not continued until the vesting date.
• The value of the compensation is dependent on the future stock price of ALIGN TECHNOLOGY INC, introducing market risk.

Risks

• The vesting of the 1,443 Restricted Stock Units is contingent upon Britt J. Vitalone's continued service until the date of the next annual meeting of stockholders.
• The ultimate value of the granted RSUs is subject to the future market price fluctuations of ALIGN TECHNOLOGY INC's common stock.

Future Outlook

The vesting of the granted Restricted Stock Units is tied to the date of the next annual meeting of stockholders, contingent on the Director's continued service, indicating an expectation of ongoing commitment.

Management Comments

• No direct quotes from management are provided in this Form 4 filing, which is a standard disclosure of an equity transaction.

Industry Context

Equity grants, particularly Restricted Stock Units, are a common form of executive and director compensation across various industries, including medical devices and technology, to align the interests of leadership with long-term shareholder value creation. This practice is standard for publicly traded companies like ALIGN TECHNOLOGY.

Comparison to Industry Standards

• The grant of 1,443 Restricted Stock Units to a director is a standard practice for executive compensation in publicly traded companies.
• While specific comparable companies or projects are not detailed in this Form 4, such grants are typical across the S&P 500 and similar-sized companies in the healthcare technology sector, aiming to incentivize long-term performance and retention.
• The vesting schedule tied to the next annual meeting is also a common structure for director equity awards.

Stakeholder Impact

• Shareholders: The grant aligns the Director's financial interests with shareholder value, as the value of the RSUs depends on the company's stock performance.
• Employees: No direct impact on general employees is indicated, though it reflects the company's compensation practices for its leadership.
• Management/Directors: Britt J. Vitalone receives equity compensation, incentivizing his continued service and performance.

Next Steps

• The 1,443 Restricted Stock Units are expected to vest on the date of the next annual meeting of stockholders.
• Shares will be delivered to Britt J. Vitalone upon vesting, assuming his continued service.

Key Dates

Keywords

ALIGN TECHNOLOGY, ALGN, Restricted Stock Units, RSU, Insider Trading, Director Compensation, Equity Grant, SEC Form 4, Corporate Governance, Executive Compensation